October 22, 2019
  • October 22, 2019
Breaking News

Tag Archives

Afterhours Healthcare Gainer to Track: Mylan N.V. (NASDAQ:MYL)

by on July 2, 2019 0
The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the MYL is 0.40%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional... Read More

BlackBerry Limited (NYSE:BB) and LG partnered for advancements in connected and autonomous vehicle technology

by on June 28, 2019 0
BlackBerry Limited (NYSE:BB) and LG have partnered for advancements in connected and autonomous vehicle technology. The two companies have partnered for a collaborative supply agreement to support the development of next-generation infotainment systems, digital instrument cluster, digital consolidated cockpit, telematics and more for key global OEMs. For the new systems, BlackBerry will provide LG... Read More

T-Mobile and Sprint Corporation (NYSE:S) will upgrade 85 percent of coverage areas in Pennsylvania to 5G

by on June 28, 2019 0
T-Mobile and Sprint Corporation (NYSE:S) will upgrade 85 percent of their coverage areas in Pennsylvania to 5G, but they have not said whether the proposed $26 billion merger of the nation’s third- and fourth-largest wireless carriers will create new Pennsylvania jobs. Sprint Corporation (NYSE:S), a Technology sector firm, traded 11.51 Million shares in last... Read More

Fiat Chrysler Automobiles N.V. (NYSE:FCAU) plans to eliminate third shift at Windsor, Ont., minivan plant

by on June 26, 2019 0
Fiat Chrysler Automobiles N.V. (NYSE:FCAU) plans to eliminate the third shift at its Windsor, Ont., minivan plant on Oct. 21, three weeks later than originally planned, due to a fleet order. FCA pushed the elimination date back from Sept. 30 “to accommodate a large order,” spokeswoman LouAnn Gosselin said in a statement. “After that date, the plant will... Read More

Theravance Biopharma Ireland & Mylan (NASDAQ:MYL) expanded current development and commercialization agreement for nebulized revefenacin

by on June 24, 2019 0
Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (and Mylan N.V. Mylan N.V. (NASDAQ:MYL) announced the expansion of the companies’ current development and commercialization agreement for nebulized revefenacin to include China and certain adjacent territories. Revefenacin, marketed as YUPELRI® in the U.S., is a long-acting muscarinic antagonist (LAMA), which is the first and only once-daily, nebulized bronchodilator approved for the treatment of chronic obstructive... Read More